A Phase 0 study of dasatinib in endometrial cancer

Duska, Linda

441 - Poster Session B
A Phase 0 study of dasatinib in endometrial cancer

Sunday, March 23, 2014: 4:40 PM

West Exhibit Hall (Tampa Convention Center)

L. Duska¹, H. Lothamer¹, W. Faust², G. Petroni³, P. M. Fracasso³ and S. Parsons³
¹University of Virginia Health System, Charlottesville, VA, ²University of Virgnia, Charlottesville, VA, ³University of Virginia, Charlottesville, VA

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

441 - Poster Session B
A Phase 0 study of dasatinib in endometrial cancer

441 - Poster Session B A Phase 0 study of dasatinib in endometrial cancer

441 - Poster Session B
A Phase 0 study of dasatinib in endometrial cancer